Sygnis Pharma AG – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 03/31/04 FY 2004

ended 03/31/03 FY 2003 – amended

ended 03/31/03 FY 2003

ended 03/31/02 FY 2002

Prospectuses and Registrations Filter

Tender offer for foreign entity

Securities registration termination

Updated info for already-effective prospectus

Shelf registration – amended

Shelf registration

Ownership Filter

Price T Rowe Associates Inc

Trega Biosciences Inc

Trega Biosciences Inc

News Filter

Counter-Proposals for the Extraordinary Shareholders’ Meeting of LION Bioscience AG to Be Held in Eppelheim on March 24, 2005 Re Agenda Item 1: Adoption of a Resolution on a New Strategic Direction for the Company

Invitation to the Extraordinary Shareholders’ Meeting

Ad Hoc-Release LION Bioscience Announces Extraordinary Shareholder Meeting to Reorganize the Company

Consolidated Financial Statements According to U.S. GAAP for the Nine Month Period Ended December 31, 2004 of LION Bioscience Aktiengesellschaft Heidelberg, Germany

Ad-Hoc LION Bioscience Announces Realignment

Proxies

No filings in this category.

Other Filter

Appointment of agent for service of process and undertaking